Company intelligence / Profile preview
EpiVario
Philadelphia, Pennsylvania, United Statesepivario.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
EpiVario develops novel small molecule therapeutics that modulate epigenetic processes involved in long-term memory formation. Their lead approach targets the enzyme ACSS2 to disrupt maladaptive memories underlying PTSD and substance use disorders. The company has received NIH grants for preclinical research into treatments for opioid, cocaine, and alcohol use disorder. They have also licensed their portfolio of ACSS2 inhibitor compounds to ReEngage Therapeutics for cancer indications.
- Therapeutic areas
- PsychiatryNeurology
- Modalities
- small molecules (specifically neuroepigenetic modulators, ACSS2 inhibitors)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
ReEngage Therapeutics (licensed portfolio of ACSS2 inhibitors for oncology applications)
Beyond the preview
Go deeper on EpiVario.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EpiVario.